Oura's listing bet: a hardware firm priced as a software platform

A company that sells a $350 ring is asking investors to value it like a company that sells a subscription. Oura, the Finnish maker of the smart ring of the same name, plans a New York listing that could raise up to $3bn and value it at more than $16bn, with Goldman Sachs and Morgan Stanley among the banks leading the deal. Existing shareholders are expected to sell a large slice of the offering, a detail that signals who wants out and at what price. The real question is not whether Oura sells health gadgets successfully; it does. It is whether the business underneath the gadget can grow into the recurring-revenue story the price requires.

Ringing the till

The numbers look like a startup in full flight. Revenue rose from $217m in 2023 to $396m in 2024 and to roughly $924m in 2025, per Oura's filings with the Finnish authorities, and the company has talked of roughly doubling again to about $2bn in its current fiscal year. More than five million people now pay for membership, and around 5.5m rings have been sold since the first model reached backers in 2015. It is a rare consumer-electronics company with real pricing power and, by one estimate, a 52% gross margin on the hardware itself.

But look at where the money comes from, and the growth story acquires a different shape. Roughly 80% of revenue is hardware, the sale of rings at several hundred dollars apiece; only about 20% is subscription. That split is the whole contest of the listing. A hardware business trading at a software valuation lives or dies on whether the recurring share of revenue rises fast enough to justify the multiple, before the hardware underneath it behaves like consumer electronics usually does: commoditised, price-competitive, and hard to keep at premium margins.

The 79% nobody can measure

The bull case rests on a claim of dominance the market cannot quite size. Oura is said to hold on the order of a 79% share of the global smart-ring category. Yet the two research firms that count the market disagree on its total size by roughly a fifth — one puts 2026 shipments near 4.9m units, another near 6m — and neither reliably apportions who sold what to whom. "Monopoly" is asserted rather than demonstrated.

The competitive gap is real, for now. Apple shelved its ring project rather than cannibalise the Watch; Samsung's Galaxy Ring is a cheaper also-ran; Whoop sells no hardware at all, financing its strap through a subscription that bundles in the device. Oura's advantages — a decade of sleep data, a refined app, a social cachet the rivals lack — are genuine. The trouble is that they fund a recurring business that is still the minority of revenue, and that recurring business depends on convincing owners to keep paying.

That dependence is the source of both Oura's promise and its friction. The subscription, roughly $70 a year, is folded into the cost of buying a ring and effectively required after the first year to see the insights that make the device worth wearing. Users resent this — buy a $400 health tracker and discover that without a monthly payment it shows "almost nothing useful," as a typical complaint runs — and rivals sell no-subscription rings to exploit the irritation. The model is defensible as a way to lock in predictable revenue in an unpredictable hardware market. But it converts the question of how many rings Oura sells into a harder question: how many owners it keeps paying, each year, indefinitely.

The tape tells the story

Two features of this capital-raising illuminate the incentives beneath the pitch. In January, Oura's board ran a tender that priced existing shares at a discount of about a quarter to the $10.9bn valuation the company had carried since October. Tenders are ordinary machinery for giving early holders liquidity, and a discount to the last round is common when growth has softened. Yet it is still an internal price, set months before the IPO, and it is materially below the price the company is now asking the public to pay. When a founder-led firm floats with insiders selling a significant portion of the deal rather than holding, the arithmetic of who gets value and who pays for it is naked on the page.

The other signal is the insistence on subscriptions themselves. Tom Hale, Oura's chief executive, has been explicit that the company has no plans to abandon the model even as rivals compete on cheaper hardware without recurring fees, arguing that member revenue buys the accuracy that keeps the data useful. There is a strategic logic to this, but it is also the only way the $16bn price is ever reached. A gadget maker growing revenue by doubling every year is impressive; a platform that converts a large, locked-in base into high-margin recurring revenue is the kind of business justified at 20 or 30 times sales. Oura's future is whichever of those descriptions turns out to be true.

The listing is therefore a bet with identifiable winners and losers. The early investors and employees cashing out take a valuation set largely by the story of what Oura might become. The retail buyer who arrives after the pop is priced on the same story, and is relying on the hard part — that a premium device in a contested category, sold mostly for a one-time hardware price, becomes the annuity the multiple assumes. Whether the ring converts its owners into durable subscribers will take years to prove. A reader should not confuse the confidence of the price with the certainty of the subscription.

That is the whole risk in a sentence. A split of 20% subscription to 80% hardware is an opportunity precisely because it is the opening of a transition, and a trap precisely because most transitions of this kind never finish. The price Oura commands is a prediction that this one succeeds. Prudence treats it as such: a bet on the conversion itself, not on the ring in the hand.